Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 18Head & Neck 7Breast 6Thoracic 5Genitourinary 5Other hematologic neoplasm 2Lymphoid 2Tumor-Agnostic 1Sarcoma 1Other 1Endocrine 1Classical hematology 1CNS 1

Conditions

Neoplasms 1Mucositis 1Esophagitis 1

Interventions

Exercise 27Metformin 24Methods 14Radiotherapy 13Early Intervention, Educational 13Educational Status 12Counseling 12Surveys and Questionnaires 10Standard of Care 10Nutrition Assessment 9Resistance Training 8Diet Therapy 8Cisplatin 8naloxegol 7Tirzepatide 7Diet 7alvimopan 6Psychiatric Rehabilitation 6Fibroblast Growth Factor 7 6Caloric Restriction 6Radiation 5Low-Level Light Therapy 5Liraglutide 5Injections 5Exenatide 5Dexamethasone 5Cryotherapy 5semaglutide 4angiotensin I (1-7) 4Vitamin D 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Dietary Supplements × Other × Clear all
NCT03228147 2017-11-17

Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment

Rutgers, The State University of New Jersey

Phase NA Completed
30 enrolled
Other

Esophagitis, Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡